-- 据周四提交给上海证券交易所的文件显示，黑龙江中邦药业（SHA:603567）的两款产品在中国传统药品采购项目中中标。 文件称，这两款产品分别是中邦药业用于儿童的速效糖浆（适用于退烧和咽喉痛）以及用于治疗心绞痛或胸痛的向丹注射液。
Related Articles
Research
Research Alert: Bce Reports Better-than-expected Results On Ai-powered Businesses
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:BCE reported Q1 2026 revenue growth of 4.0% to $6,168M due to the Ziply Fiber acquisition, despite a significant 56.1% dividend reduction to $0.4375. Adjusted EPS of $0.63 beat the consensus of $0.58 but declined 8.7% Y/Y as adjusted EBITDA grew 2.9% to $2,631M with margin compression of 40 bps to 42.7%. The Ziply acquisition contributed $234M in revenue and $102M in EBITDA, demonstrating strategic value in expanding BCE's growth opportunities. Management is targeting $1.5B in cost savings by 2028 and emphasizing capital reallocation flexibility between Canadian and U.S. operations. Wireless showed improved competitive positioning with 16,947 postpaid net additions versus 9,598 losses in Q1 2025, while broadband performance was notably strong with 17,782 high-speed Internet net additions compared to 3,744 in the prior year. We will listen for updates on cost transformation progress, regulatory changes, and digital media initiatives on the upcoming call.
$BCE
US Markets
McDonald's First-Quarter Results Top Street Views Despite 'Challenging' Environment
McDonald's (MCD) reported better-than-expected first-quarter results on Thursday, while comparable sales rebounded more than market estimates despite what the company described as a "challenging" environment.The fast-food giant's adjusted earnings came in at $2.83 a share for the March quarter, up from $2.67 the year before, topping the consensus on FactSet for $2.74. Revenue increased 9% to $6.52 billion, surpassing the Street's view for $6.47 billion.The stock was up 3.2% in the most recent premarket activity.Comparable sales rose 3.8%, rebounding from a 1% decline in the prior-year quarter. The average analyst estimate on FactSet was for growth of 3.7%."McDonald's delivered this quarter," Chief Executive Chris Kempczinski said in a statement. "Our 6% global system-wide sales growth shows how we executed with discipline, proving that we can drive results even in a challenging environment."US same-store sales grew 3.9%, mainly buoyed by positive check growth, according to the company.UBS Securities said earlier in the week it expected McDonald's to record a 3.5% gain in US comparable sales versus consensus for a 4% increase, with momentum seen moderating into the ongoing quarter amid softer trends due to high fuel prices and macro pressures.Same-store sales advanced 3.9% in the international operated markets, led by the UK, Germany and Australia. In the international developmental licensed markets, the metric moved 3.4% higher, led by Japan, McDonald's said.Total operating costs and expenses rose to $3.56 billion from $3.31 billion last year.On Wednesday, Restaurant Brands International (QSR) posted first-quarter results above Wall Street's estimates, while the Burger King parent's comparable sales growth was in line with consensus. Last week, KFC and Taco Bell owner Yum Brands (YUM) reported better-than-expected first-quarter results.
$MCD
Research
Wedbush Downgrades Cross Country Healthcare to Neutral From Outperform, Cuts Price Target to $13.25 From $15 Amid Knox Lane Deal
Cross Country Healthcare (CCRN) has an average rating of hold and mean price target of $11.67, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
$CCRN